{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:05:09Z","timestamp":1789621509312,"version":"build-2803163510"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Subcutaneous insulin resistance (SIR) is a rare condition characterized by impaired responsiveness to subcutaneous insulin despite preserved intravenous insulin efficacy. The coexistence of SIR with rapid loss of endogenous insulin secretion following exogenous insulin exposure has rarely been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 47-year-old Chinese man initially classified as having type 2 diabetes (T2D) had preserved endogenous insulin secretion (random C-peptide, 4.59 ng\/mL) and negative insulin autoantibody (IAA), glutamic acid decarboxylase antibody, and insulinoma-associated protein 2 antibody at diagnosis. Shortly after initiation of subcutaneous insulin therapy, he developed pruritic, erythematous, and indurated injection-site lesions with progressive hyperglycemia and subsequently presented with diabetic ketoacidosis. C-peptide became undetectable, whereas IAA increased to &amp;gt;175 IU\/mL. Intravenous insulin consistently restored glycemic control, while several subcutaneous insulin preparations were initially ineffective, indicating a marked route-dependent difference in insulin responsiveness. Subcutaneous insulin responsiveness later recovered, first with biphasic protamine human insulin 40\/60 and subsequently with insulin analogues, despite persistent IAA positivity. At recent follow-up, 14-day continuous glucose monitoring showed a mean glucose of 7.6 mmol\/L, time in range of 80%, and time below range of 3%. A heterozygous\n                      <jats:italic>WFS1<\/jats:italic>\n                      variant (NM_006005.3:c.2147C&amp;gt;G, p.Ala716Gly) was identified as an exploratory finding of uncertain clinical significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This case highlights the coexistence of rapid loss of endogenous insulin secretion and severe but reversible SIR following exogenous insulin exposure. Preserved intravenous insulin responsiveness and recovery of subcutaneous insulin efficacy despite persistent IAA positivity underscore the dynamic and route-specific nature of this phenotype. The underlying mechanism remains uncertain, and no causal relationship with the\n                      <jats:italic>WFS1<\/jats:italic>\n                      variant can be inferred. Recognition of this pattern may facilitate appropriate insulin delivery and longitudinal monitoring.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1962271","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:50:21Z","timestamp":1789620621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Rapid loss of endogenous insulin secretion and reversible subcutaneous insulin resistance following exogenous insulin exposure in a patient initially diagnosed with type 2 diabetes"],"prefix":"10.3389","volume":"17","author":[{"given":"Si","family":"Wen","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Guangzhou Dongsheng Hospital (Guangzhou Geriatric Rehabilitation Hospital)","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiya","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongguang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/EC-17-0309","article-title":"Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients","volume":"7","author":"Hu","year":"2018","journal-title":"Endocr Connect"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.08.031","article-title":"Insulin administration may trigger pancreatic beta-cell destruction in patients with type 2 diabetes","volume":"79","author":"Nakamura","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1759","article-title":"Insulin administration may trigger type 1 diabetes in Japanese type 2 diabetes patients with type 1 diabetes high-risk HLA class II and the insulin gene VNTR genotype","volume":"99","author":"Nishida","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i9.109130","article-title":"Exogenous insulin-associated autoimmunity and the emergence of double diabetes in type 2 diabetes","volume":"16","author":"Li","year":"2025","journal-title":"World J Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.844040","article-title":"Insulin allergy to Detemir followed by rapid onset of diabetic ketoacidosis: a case report and literature review","volume":"13","author":"Teo","year":"2022","journal-title":"Front Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s1262-3636(07)70069-1","article-title":"Extreme subcutaneous insulin resistance: a misunderstood syndrome","volume":"29","author":"Soudan","year":"2003","journal-title":"Diabetes Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/ncpendmet0351","article-title":"Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners","volume":"3","author":"Hanafusa","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2337\/dbi20-0017","article-title":"Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel","volume":"69","author":"Buzzetti","year":"2020","journal-title":"Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13340-023-00679-1","article-title":"New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)","volume":"15","author":"Shimada","year":"2024","journal-title":"Diabetol Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607173150302","article-title":"In search of the subcutaneous-insulin-resistance syndrome","volume":"315","author":"Schade","year":"1986","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01567.x","article-title":"Insulin allergy: clinical manifestations and management strategies","volume":"63","author":"Heinzerling","year":"2008","journal-title":"Allergy"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/dci24-0032","article-title":"Hyperglycemic crises in adults with diabetes: a consensus report","volume":"47","author":"Umpierrez","year":"2024","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1962271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:50:44Z","timestamp":1789620644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1962271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":12,"alternative-id":["10.3389\/fendo.2026.1962271"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1962271","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1962271"}}